Sorry, you need to enable JavaScript to visit this website.

COVID-19

Alternative labels
Coronavirus disease 2019
Novel coronavirus pneumonia
2019-nCoV acute respiratory disease
Subject Hierarchy
Broader terms
Infectious diseases
Current term
COVID-19
Permalinks
APO URI

ADVERTISEMENT

Working paper

Financing firms in hibernation during the COVID-19 pandemic


The COVID-19 pandemic has halted economic activity worldwide, hurting firms and pushing many of them toward bankruptcy. This paper discusses four central issues that have emerged in the academic and policy debates related to business financing during the downturn.
Report

Aged care and COVID-19: a special report


The COVID-19 pandemic has been the greatest challenge Australia's aged care sector has faced. Those who have suffered the most have been the residents, their families and aged care staff. This report makes six recommendations, among them - a requirement that the Australian government report to the Australian Parliament no later than 1 December 2020...
Fact sheet

Fact Check: Tony Abbott says Victoria's coronavirus lockdown is the most severe tried in the world outside Wuhan. Is he correct?


Former prime minister Tony Abbott labelled Victoria a "health dictatorship" and called for its COVID-19 restrictions to be eased, claiming the state responded to its second wave of coronavirus infections with "the most severe lockdown tried anywhere in the world outside of Wuhan". Verdict: Mr Abbott's claim is wrong.
Report

The Australian cyber security skills and jobs NSW study


In early 2020, the Australian Information Security Association (AISA) partnered with NSW Treasury to undertake a research project to identify potential cyber security skills gaps and look at the impact of COVID-19 on the local cyber security industry.
Policy report

Medical capacity: an alternative to lockdowns


This paper argues that lockdowns and social distancing regulations introduced to manage the health concerns associated with COVID-19, have imposed significant social, economic and institutional costs, while being of debatable efficacy.